These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Some enzyme-substrate systems in the process of regeneration of bone tissue]. KASAVINA BS; ZENKEVICH GD; RIKHTER AI; LAUFER AL; LIRTSMAN VM; MARKOVA ON Eksp Khirurgiia; 1962; 7():56-63. PubMed ID: 14454123 [No Abstract] [Full Text] [Related]
46. The influence of hydrolysates of hyaluronate upon hyaluronidase production by micro-organisms. ROGERS HJ Biochem J; 1946 Jul; 40(4):583-8. PubMed ID: 20273647 [No Abstract] [Full Text] [Related]
47. [Clinical pharmacology and possible applications of hyaluronidase with reference to Hylase "Dessau"]. Farr C; Menzel J; Seeberger J; Schweigle B Wien Med Wochenschr; 1997; 147(15):347-55. PubMed ID: 9432805 [TBL] [Abstract][Full Text] [Related]
48. Hyaluronidase activity and hyaluronate content of the developing chick embryo heart. Orkin RW; Toole BP Dev Biol; 1978 Oct; 66(2):308-20. PubMed ID: 29813 [No Abstract] [Full Text] [Related]
49. [Role of hyaluronic acid-hyaluronidase balance in the pathogenesis of certain bullous diseases]. FOLDVARI F; NEKAM L Arch Klin Exp Dermatol; 1956; 203(5):433-9. PubMed ID: 13382174 [No Abstract] [Full Text] [Related]
50. Inhibition of hyaluronan hydrolysis catalysed by hyaluronidase at high substrate concentration and low ionic strength. Astériou T; Vincent JC; Tranchepain F; Deschrevel B Matrix Biol; 2006 Apr; 25(3):166-74. PubMed ID: 16380245 [TBL] [Abstract][Full Text] [Related]
51. Use of hyaluronidase for pharmacokinetic increase in bioavailability of intracutaneously applied substances. Wohlrab J; Wohlrab D; Wohlrab L; Wohlrab C; Wohlrab A Skin Pharmacol Physiol; 2014; 27(5):276-82. PubMed ID: 24944044 [TBL] [Abstract][Full Text] [Related]
52. Midnight footprints in the watermelon patch. Stern R Matrix Biol; 2008 Oct; 27(8):651-2. PubMed ID: 19041804 [No Abstract] [Full Text] [Related]
53. [Role of hyaluronic acid in the virulence of group A streptococci]. Burova LA; Rits M; Totolian AA Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):44-7. PubMed ID: 7034413 [TBL] [Abstract][Full Text] [Related]
54. [Hyaluronic capsule as one of the factors of hemolytic streptococcal pathogenicity]. Anatoliĭ SA Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):22-7. PubMed ID: 324183 [TBL] [Abstract][Full Text] [Related]
55. Kinetic investigation of the action of hyaluronidase on hyaluronan using the Morgan-Elson and neocuproine assays. Vercruysse KP; Lauwers AR; Demeester JM Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):55-9. PubMed ID: 7646472 [TBL] [Abstract][Full Text] [Related]
56. Production of hyaluronidase and beta-glucuronidase by Viridans streptococci isolated from gingival crevices. SCHULTZ-HAUDT SD; SCHERP HW J Dent Res; 1955 Dec; 34(6):924-9. PubMed ID: 13271666 [No Abstract] [Full Text] [Related]
57. Role of hyaluronidase and the hyaluronic acid capsule in the survival and dissemination of group A streptococci in the hamster cheek pouch. KRASNER RI; YOUNG G J Bacteriol; 1958 Oct; 76(4):349-54. PubMed ID: 13587471 [No Abstract] [Full Text] [Related]
58. Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation. Oh EJ; Kang SW; Kim BS; Jiang G; Cho IH; Hahn SK J Biomed Mater Res A; 2008 Sep; 86(3):685-93. PubMed ID: 18022803 [TBL] [Abstract][Full Text] [Related]
59. Analysis of hyaluronan content in chondroitin sulfate preparations by using selective enzymatic digestion and electrospray ionization mass spectrometry. Saad OM; Myers RA; Castleton DL; Leary JA Anal Biochem; 2005 Sep; 344(2):232-9. PubMed ID: 16081034 [TBL] [Abstract][Full Text] [Related]
60. Hyaluronic acid: a required component of beta hemolytic streptococci for infecting mice by aerosol. JOHNSON BH; FURRER W J Infect Dis; 1958; 103(2):135-41. PubMed ID: 13588063 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]